An antibody generated against a neutral phosphonate diester transition-state (TS*) analog catalyzes the formation of an amide bond between a phenylalanyl amino group and an acyl azide derived from L-alanine. The antibody is selective for L-vs. D-alanine and does not catalyze the hydrolysis of the acyl azide to an appreciable degree. A rate acceleration of 10,000-fold relative to the uncatalyzed reaction is observed. The antibody may achieve its catalytic efficiency both by acting as an entropy trap and by stabilizing the deprotonated form of the amine nucleophile. These experiments constitute a first step toward a general strategy for the generation of sequence-specific peptide ligases. We wished to investigate the requirements for catalysis of peptide bond formation using a catalytic antibody. Previously reported studies in this area focused on condensation reactions involving activated esters and-aryl amines (7, 8) . We have applied a design strategy that was found to be highly successful for bimolecular ester formation (9). Antibodies were generated against the neutral phosphonate diester 1 that contains elements ofthe acyl donor 5, acceptor 7, and leaving group in a tetrahedral geometry mimicking that of the presumed transition state (Fig. la) . One antibody was isolated that accelerated the formation of peptide 8 from the corresponding substrates and was characterized with respect to its substrate specificity and reaction kinetics. MATERIALS Diphenyl 1-(N-carbophenethyloxyamno)ethylphosphonate (10) . To a solution ofphosgene in toluene (31 ml, 1.9 M) at 00C was added phenethyl alcohol (6.0 ml, 50 mmol). N,NDimethylaniline (6.4 ml, 50 mmol) was added dropwise over a 10-min interval, and after an additional 15 min, 8 ml of methylene chloride was added, and the reaction was warmed to room temperature. After 4 h residual phosgene was removed under reduced pressure, and the crude chloroformate was treated with 2.9 M aqueous ammonia (70 ml) and stirred rapidly for 30 min. The product was extracted into 50 ml of methylene chloride. The 64.94; H 5.69; N 3.29; P, 7.28. Found: C, 64.88; H, 5.71; N, 3.27; P, 7.28. N-(4-Nitrobenzoyl)-1,3-dlaminopropane (11). To a suspension of 4-nitrobenzoyl chloride (7.2 g, 39 mmol) in 150 ml of methylene chloride at OC was added triethylamine (14 ml, 98 mmol) and 3-bromopropylamine hydrobromide (8.6 g, 39 mmol). The solution was warmed to room temperature, and after 15 min the reaction mixture was diluted with 100 ml of methylene chloride and extracted twice with 100-ml portions of 0.1 M HCO and twice with 100-ml portions of 0.1 M NaOH. The The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
The formation of amide bonds is a key step in both the chemical and biological synthesis of proteins. Solid-phase peptide synthesis has made great strides in recent years but is still generally limited to peptides and proteins offewer than 100 amino acids (1) . The ability to specifically join peptide segments in the absence of side-chain protecting groups is, therefore, an area of increasing interest. The generation of peptide ligases from proteases and lipases has been investigated by site-directed mutagenesis (2, 3) and through the use of organic solvents to favor peptide bond formation over hydrolysis (4) . In addition, specific chemical methods for peptide ligation have been developed (5, 6) .
We wished to investigate the requirements for catalysis of peptide bond formation using a catalytic antibody. Previously reported studies in this area focused on condensation reactions involving activated esters and-aryl amines (7, 8) . We have applied a design strategy that was found to be highly successful for bimolecular ester formation (9) . Antibodies were generated against the neutral phosphonate diester 1 that contains elements ofthe acyl donor 5, acceptor 7, and leaving group in a tetrahedral geometry mimicking that of the presumed transition state (Fig. la) . One antibody was isolated that accelerated the formation of peptide 8 from the corresponding substrates and was characterized with respect to its substrate specificity and reaction kinetics. MATERIALS Diphenyl 1-(N-carbophenethyloxyamno)ethylphosphonate (10) . To a solution ofphosgene in toluene (31 ml, 1.9 M) at 00C was added phenethyl alcohol (6.0 ml, 50 mmol). N,NDimethylaniline (6.4 ml, 50 mmol) was added dropwise over a 10-min interval, and after an additional 15 min, 8 ml of methylene chloride was added, and the reaction was warmed to room temperature. After 4 h residual phosgene was removed under reduced pressure, and the crude chloroformate was treated with 2.9 M aqueous ammonia (70 ml) and stirred rapidly for 30 min. The product was extracted into 50 ml of methylene chloride. The organic layer was dried (MgSO4) and cooled to 0C for 12 h to yield colorless crystals of phenethyl carbamate that were isolated by vacuum filtra- tion (4.6 g, 55%), m.p. 87-890C. To a stirred solution of the carbamate (3.3 g, 20 mmol) in triphenylphosphite (5.2 ml) and acetic acid (5.0 ml) was added acetaldehyde (1.7 ml, 30 mmol) (10) . The reaction was stirred at room temperature for 1 N-(4-Nitrobenzoyl)-1,3-dlaminopropane (11) . To a suspension of 4-nitrobenzoyl chloride (7.2 g, 39 mmol) in 150 ml of methylene chloride at OC was added triethylamine (14 ml, 98 mmol) and 3-bromopropylamine hydrobromide (8.6 g, 39 mmol). The solution was warmed to room temperature, and after 15 min the reaction mixture was diluted with 100 ml of methylene chloride and extracted twice with 100-ml portions of 0.1 M HCO and twice with 100-ml portions of 0.1 M NaOH. The (12 Aminobenzamide Hapten, Mixture of Diastereomers (1) . A solution of phosphonate 10 (0.93 g, 2.2 mmol) in 2 ml of dimethylformamide was diluted with 4 ml of water, and one equivalent of lithium hydroxide monohydrate was added (92 mg, 2.2 mmol). The mixture was heated to reflux and after 3 h cooled to room temperature. The resulting solution was extracted three times with 20-ml portions of chloroform and the aqueous layer was lyophilized to yield 0.75 g (97% isolated yield) of the lithium salt as a white hygroscopic solid, m.p. 116-119°C. The lithium salt (0.51 g, 1.4 mmol) was treated with 7.0 ml of ice-cold thionyl chloride and stirred at 0°C for 15 min. The reaction mixture was warmed to room temperature and stirred for an additional 48 h, after which time 31p {'H} NMR indicated complete conversion to the phosphonyl chloride (8 36.6, 37.1). The SOC12 was distilled under vacuum and the residue was resuspended in 10 ml of methylene chloride. The solvent was again removed by distillation and the residue resuspended in 10 ml of methylene chloride. The suspension was filtered under an inert atmosphere to remove insoluble lithium chloride. The filtrate was cooled to 0°C, and phenyllactic acid derivative 12 (0.53 g, 1.4 mmol) and triethylamine (0.35 ml, 2.5 mmol) were added. After 30 min the reaction mixture was warmed to room temperature and stirred for an additional 24 h. The solution was washed with saturated aqueous sodium bicarbonate and dried (MgSO4). The product was purified by silica gel chromatography [3% methanol in methylene chloride, followed by a second purification using a gradient of 49:49:2 (vol/vol) ethyl acetate/hexanes/methanol to a 48/48/4 mixture of the same components, Rf = 0.13, 0.16, 0.19, mixture of diastereomers]. The nitrobenzamide product 2 was isolated as a pale yellow foam (0.19 g, 19%, mixture of diastereomers). To a solution of the nitrobenzamide (25 mg, 35 ,umol) in 3.0 ml of methanol was added 6 mg of 10% (wt/wt) palladium on carbon. The mixture was stirred under positive hydrogen pressure for 1 h. The mixture was reduced in vacuo without removal of the catalyst and purified by silica gel chromatography (5% methanol in methylene chloride, Rf = 0.47) to give 19 mg (79%) of 1 as a colorless oil; 'H NMR (500 MHz, C2HC13) 6 Protein-Hapten Conjugates. Hapten 1 (6.8 mg, 10 Ismol) was dissolved in 1.0 ml of tetrahydrofuran, and 56 ,u of 0.20 M thiophosgene (11 ,umol) in tetrahydrofuran was added. After 3 h the reaction was judged to be complete by TLC. The crude isothiocyanate was characterized by mass spectrometry (FAB+), m/z 715 (MH+). Exact mass: Calcd for (C37H39N407PS)H+: 715.2355. Found: 715.2354. The solvent was removed in vacuo and the residue was dissolved in 0.22 ml of dimethyl sulfoxide. Bovine serum albumin (BSA, 40 mg) was dissolved in 4.0 ml of water and 0.1 M NaOH was added dropwise until the pH reached 8.5. The BSA solution was stirred at room temperature and 0.10 ml (4.6 Amol) ofthe isothiocyanate solution was added. Additional one-drop portions of 0.1 M NaOH were added over 1 h to maintain the pH between 8.5 and 9.0. After 12 h the solution was clarified by centrifugation at 14,000 rpm in a microcentrifuge for 10 min. The supernatant was dialyzed exhaustively against PBS (15 mM sodium phosphate/150 mM NaCl, pH 7.5), and filtered (0.2 ,um, pore size). The final protein concentration was determined to be 9.4 mg/ml by the method of Bradford (12) . The concentration of hapten was determined by UV absorbance at 280 nm (e = 14,700) to give an epitope density of 2.4 hapten molecules per BSA monomer. The keyhole limpet hemocyanin conjugate was prepared similarly to give an epitope density of 9.6. N-(4-Nitrobenzoyl)-N'-L-phenyl1lanyl-1,3-diaminopropane (7). This compound was prepared in protected form from N-t-Boc-L-phenylalanine, where Boc is butoxycarbonyl, by a procedure similar to that described for the preparation of 12. The protected amine (0.52 g, 1.1 mmol) was dissolved in 5.0 ml of methylene chloride and treated with 5.0 ml of trifluoroacetic acid. After 1 h the reaction was judged to be complete by TLC and concentrated in vacuo, and the product was N-Carbophenethyloxy-L-alanyl Azide (5) . N-Carbophenethyloxy-L-alanine was converted to the corresponding methyl ester by using conditions analogous to those described for the preparation of ester 3. The product was isolated as a colorless oil (86%); 1H NMR (400 MHz, C2HC13) 81 
N-Carbophenethyloxy-D-alanyl-L-phenylalanyl-(N'-4-nitrobenzoyl)-1,3-diaminopropane (9)
. This compound was prepared from amine 7 and N-carbophenethyloxy-D-alanine using the conditions analogous to those described for the preparation of ester 3. The product was obtained in 73% yield RESULTS AND DISCUSSION Catalysis of peptide bond formation in aqueous solution presents several challenges. Activated carboxyl groups are necessary for thermodynamically favorable reactions, but these groups are susceptible to hydrolysis. Consequently, effective catalysts must selectively catalyze the reaction with an amine nucleophile in the presence of55 M water. Catalysts must also be selective for the a-amino group to avoid acylation of other primary amino groups in the peptide fragments. The amino group must be unprotonated to act as a nucleophile, but alkyl amines have pKa values of 10 and are, therefore, present almost exclusively in the protonated form at physiological pH. The a-amino group of a peptide fragment may have a pKa that is as many as 3 units lower, but in the majority of cases this group is still predominantly in the protonated form at pH 7.0.
We anticipated that antibodies complementary to hapten 1 would bind to both amine nucleophile 7 and an activated carboxylic acid derivative, 3, 4, 5, or 6, and position these substrates in an orientation suitable for reaction, thereby reducing the entropy of activation for the reaction. The tetrahedral geometry at phosphorus and the P==O dipole reflect the geometry and electronic character of the expected transition state. The neutral phosphonate group might be expected to elicit a binding pocket that would stabilize the corresponding uncharged amine nucleophile relative to its protonated form. While the corresponding phosphonamidate might more accurately reflect the developing ionic character of the amino group in the transition state, it was not considered as a potential hapten due to concerns about its stability in serum.
The synthesis of hapten 1 is outlined in Fig. lb . Hapten 1 was coupled to carrier proteins BSA and keyhole limpet hemocyanin by using a thiourea linkage, and the keyhole limpet hemocyanin hapten conjugate was used to immunize Swiss Webster mice. Standard protocols were used to isolate 28 clonal cell lines that produced antibodies specific for hapten 1 (15) . Ascites fluid was produced in irradiated Swiss Webster mice for 20 cell lines and purified by protein A/G affinity chromatography. Antibodies werejudged to be >95% pure by polyacrylamide gel electrophoresis.
Antibodies were screened for catalysis of the reaction of Land D-alanine phenyl esters 3 and 4 with phenylalanine amine 7 to form the corresponding amides 8 and 9. Substrates and antibodies were combined in 15 mM sodium phosphate (pH 7.4) containing 150 mM sodium chloride and 4 mM sodium azide, and product formation was assayed by HPLC. Reactions were carried out in the presence of sodium azide to provide the more reactive acyl azides 5 and 6 in situ as substrates for the antibody (16) . Two antibodies were found to accelerate the reaction; both selectively catalyze the reaction of the L-alanine-derived substrate 5 in preference to its enantiomer 6. No product could be detected after 24 h in the absence of sodium azide (detection limit, =100 nM). The enhanced reactivity of the acyl azide may be due to the greater leaving group ability of azide relative to phenol. An alternative hypothesis is that the azide group participates in the proton transfer steps required to form the tetrahedral intermediate (16) . Attempts to examine the reaction of amine 7 with a cyanomethyl ester analog of 3 were complicated by a competing reaction of the amine with the decomposition products of the ester leaving group. Antibody 9B5.1 was characterized in detail.
Kinetic parameters for antibody 9B5.1 were determined for reaction mixtures composed of 143-952 AM amine 7, 95-381 ,uM ester 3, and 16 ,uM antibody in 100 mM Mes, pH 5.8/48 mM sodium azide. HPLC analysis of reaction mixtures containing phenyl ester 3 in the absence of amine nucleophile revealed a peak corresponding to an intermediate that forms rapidly during the first hour of reaction, remains at a nearly constant concentration for -16 h under the assay conditions, and finally decays. This peak was assigned as the acyl azide intermediate 5 by coinjection with authentic material. Because purified acyl azide hydrolyzes rapidly under the assay conditions, it was preferable to make use of the steady-state concentrations of acyl azide 5 produced from ester 3 in the presence of sodium azide during the reaction. The steadystate concentrations of azide 5 were determined by HPLC. The azide peak was monitored under the reaction conditions, and concentrations were determined by calibration against authentic material by using 6-nitroquinoline as an internal standard. The azide concentration was found to vary by <8% over the course of the reaction. Initial rates were determined by HPLC for a range of concentrations of acyl azide 5 and amine 7. Reaction rates in the absence of antibody were measured under identical conditions, and the catalyzed rates were determined by subtraction of these background rates. Families of Lineweaver-Burk plots were constructed by holding one substrate concentration constant while varying the concentration of the other (Fig. 2a) . The slopes and y-axis intercepts obtained from these analyses were replotted as functions of inverse substrate concentration to give the true maximum rate, Vmow, as 1.9 uM-min1, which corresponds to a rate constant, kcat, of 0.059 min-1 per antibody binding site (Fig.  2b) . The Michaelis constant, Km, is 15 ,uM for acyl azide S and M-l min1 for the amine. Analysis of the uncatalyzed rates gives the second-order rate constant kunt = 0.37 M-l min-', affording a rate acceleration (kat/Km/kuncat) of 1.0 x 104. The family of plots in Fig. 2a intersects on the horizontal axis, indicating that the antibody exhibits sequential binding. This result is similar to that described previously for an antibody generated against another phosphonate diester (9). No significant product inhibition was observed; this is consistent with the different hybridization states of the amide product 8 and phosphonate hapten 1.
The antibody-catalyzed reaction was monitored at several pH values (pH 5.8, 6.5, 7.3, and 8.0). The maximal rate for the antibody-catalyzed reaction occurs at pH =7.3. In contrast, the rate of the uncatalyzed reaction increases steadily with increasing pH. The shift in the pH optimum of the antibody-catalyzed reaction to lower pH relative to the uncatalyzed reaction suggests that the antibody may stabilize the unprotonated form of amine 7. This presents the possibility of using an antibody to specifically activate a single amino group in a peptide, obviating the need for side-chain protecting groups. The decrease in rate of the antibodycatalyzed reaction at higher pH may reflect an ionizable active site group or a competing hydrolysis pathway.
The antibody-catalyzed reaction is completely inhibited by addition of 63 uM hapten 2. The binding of hapten 1 to antibody 9B5.1 was assayed by measuring the enhancement of hapten fluorescence upon binding to the antibody. Titration of hapten with antibody followed by Scatchard analysis afforded the dissociation constant Kd for the antibody-i complex as 19 nM (Fig. 3) . The differential binding of the antibody to the transition-state TS* analog relative to the substrates (8, 9) is not as great as that observed for the series of fluorescence titrations were performed using a PerkinElmer LS-5B luminescence spectrometer with samples of hapten 1 in 100 mM Mes (pH 6.0) containing 1% methanol. These samples were titrated with antibody 9B5.1 over a range of concentrations up to E10-fold higher than the concentration of hapten. Fluorescence was measured at 360 nm with excitation at 305 nm. Fluorescence was corrected for volume change over the course of the titration and for fluorescence due to added antibody, and the fraction of the hapten bound (R) was calculated based on the titration end points. Because hapten 1 was obtained as a mixture of four diastereomers, the relevant concentration of hapten is assumed to be one-fourth of the total concentration. Data corresponding to 20-80%o saturation of hapten were analyzed using Scatchard analysis (17) 6 relative to the L-alanine-derived azide 5 .
We have demonstrated selective catalysis of amide bond formation by an antibody. This may be a first step toward a general strategy for the generation of peptide ligases with tailored specificities. The extension of our phosphonate diester design from ester formation to amide formation highlights the greater complexity of amide formation and the need for further refinements in hapten structure.
